Presentation TCT Top Late Breaking Trials:TAVR Studies Presenter: Gregg W. Stone November 03, 2014 REGISTER for free or LOG IN to view this content Aortic Valve Presentation Up Next Presentation AHA 2014 Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent Presenter: Dean J. Kereiakes November 16, 2014 More slides + Presentation One-year Follow-up of the Melody Transcatheter Pulmonary Valve Multicenter Postapproval Study Presenter: Aimee K. Armstrong December 01, 2014 Presentation Reguritant Volume Informs Rate of Progressive Cardiac Dysfuntion in Asymptomatic Patients with Chronic Aortic or Mitral Regurgitation Presenter: K. Kusunose December 10, 2014 We Recommend
Presentation AHA 2014 Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent Presenter: Dean J. Kereiakes November 16, 2014
Presentation One-year Follow-up of the Melody Transcatheter Pulmonary Valve Multicenter Postapproval Study Presenter: Aimee K. Armstrong December 01, 2014
Presentation Reguritant Volume Informs Rate of Progressive Cardiac Dysfuntion in Asymptomatic Patients with Chronic Aortic or Mitral Regurgitation Presenter: K. Kusunose December 10, 2014